129 related articles for article (PubMed ID: 37322627)
1. Abnormal expression of long non-coding RNA FGD5-AS1 affects the development of ovarian cancer through regulating miR-107/RBBP6 axis.
Zhang W; Shi J; Liu G
Chin J Physiol; 2023; 66(3):171-180. PubMed ID: 37322627
[TBL] [Abstract][Full Text] [Related]
2. LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p.
Aichen Z; Kun W; Xiaochun S; Lingling T
Apoptosis; 2021 Jun; 26(5-6):348-360. PubMed ID: 33974163
[TBL] [Abstract][Full Text] [Related]
3. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.
Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D
Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241
[TBL] [Abstract][Full Text] [Related]
4. LncRNA FGD5-AS1 promotes tumor growth by regulating MCL1 via sponging miR-153-3p in oral cancer.
Ge C; Dong J; Chu Y; Cao S; Zhang J; Wei J
Aging (Albany NY); 2020 Jul; 12(14):14355-14364. PubMed ID: 32675387
[TBL] [Abstract][Full Text] [Related]
5. Long Noncoding RNA FGD5-AS1 Knockdown Decrease Viability, Migration, and Invasion of Non-Small Cell Lung Cancer (NSCLC) Cells by Regulating the MicroRNA-944/MACC1 Axis.
Lv J; Li Q; Ma R; Wang Z; Yu Y; Liu H; Miao Y; Jiang S
Technol Cancer Res Treat; 2021; 20():1533033821990090. PubMed ID: 33550920
[TBL] [Abstract][Full Text] [Related]
6. Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer by Regulating the miR-493-5p/DDX5 Axis.
Cui F; Luo P; Bai Y; Meng J
Technol Cancer Res Treat; 2021; 20():1533033821990007. PubMed ID: 33550957
[TBL] [Abstract][Full Text] [Related]
7. Thalidomide suppresses angiogenesis and immune evasion via lncRNA FGD5-AS1/miR-454-3p/ZEB1 axis-mediated VEGFA expression and PD-1/PD-L1 checkpoint in NSCLC.
Xia Y; Wang WC; Shen WH; Xu K; Hu YY; Han GH; Liu YB
Chem Biol Interact; 2021 Nov; 349():109652. PubMed ID: 34520751
[TBL] [Abstract][Full Text] [Related]
8. Targeting the lncRNA FGD5-AS1/miR-497-5p/PD-L1 Axis Inhibits Malignant Phenotypes in Colon Cancer (CC).
Zhang L; Cai X; Dai Y; Chen Y; Yu J; Zhou Y
Biomed Res Int; 2022; 2022():1133332. PubMed ID: 35845947
[TBL] [Abstract][Full Text] [Related]
9. LncRNA FGD5-AS1 Alleviates Inflammation in Allergic Rhinitis through the miR-223-3p/COX11 Axis.
Li B; Yu X; Pang F
Int Arch Allergy Immunol; 2024; 185(3):201-211. PubMed ID: 38071964
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA FGD5-AS1 promotes non-small cell lung cancer cell proliferation through sponging hsa-miR-107 to up-regulate FGFRL1.
Fan Y; Li H; Yu Z; Dong W; Cui X; Ma J; Li S
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31919528
[TBL] [Abstract][Full Text] [Related]
11. The lncRNA SLCO4A1-AS1/miR-876-3p/RBBP6 axis regulates cell proliferation and apoptosis in acute lymphocytic leukemia via the JNK signaling pathway.
Mao J; Gao W; Xue L; Wang J; Zhao L
Int J Lab Hematol; 2021 Oct; 43(5):1050-1061. PubMed ID: 33683013
[TBL] [Abstract][Full Text] [Related]
12. LncRNA FGD5-AS1/miR-5590-3p axis facilitates the proliferation and metastasis of renal cell carcinoma through ERK/AKT signalling.
Yang Y; Dong MH; Hu HM; Min QH; Xiao L
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8756-8766. PubMed ID: 32964964
[TBL] [Abstract][Full Text] [Related]
13. FXR1 promotes glioma progression by downregulating microRNA-124-3p through long noncoding RNA FGD5-AS1 upregulation.
Gong X; Huang M; Chen L; Zeng H
Acta Neurol Belg; 2023 Aug; 123(4):1453-1464. PubMed ID: 37074635
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA FGD5-AS1 promotes colorectal cancer cell proliferation, migration, and invasion through upregulating CDCA7 via sponging miR-302e.
Li D; Jiang X; Zhang X; Cao G; Wang D; Chen Z
In Vitro Cell Dev Biol Anim; 2019 Sep; 55(8):577-585. PubMed ID: 31332696
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA FGD5-AS1 enhances osteosarcoma cell proliferation and migration by targeting miR-506-3p/RAB3D axis.
Li C; Lin X; Zhang C; Wan L; Yin J; Wang B
Hum Cell; 2021 Jul; 34(4):1255-1265. PubMed ID: 33891267
[TBL] [Abstract][Full Text] [Related]
16. EBF1-mediated up-regulation of lncRNA FGD5-AS1 facilitates osteosarcoma progression by regulating miR-124-3p/G3BP2 axis as a ceRNA.
Shuang O; Zhou J; Cai Z; Liao L; Wang Y; Wang W; Xu M
J Orthop Surg Res; 2022 Jun; 17(1):332. PubMed ID: 35761386
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA OIP5-AS1 plays an oncogenic role in ovarian cancer through targeting miR-324-3p/NFIB axis.
Liu QY; Jiang XX; Tian HN; Guo HL; Guo H; Guo Y
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7266-7275. PubMed ID: 32706064
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA AFAP1-AS1 facilitates ovarian cancer progression by regulating the miR-107/PDK4 axis.
Liu B; Yan L; Chi Y; Sun Y; Yang X
J Ovarian Res; 2021 Apr; 14(1):60. PubMed ID: 33926489
[TBL] [Abstract][Full Text] [Related]
19. FGD5-AS1 Inhibits Osteoarthritis Development by Modulating miR-302d-3p/TGFBR2 Axis.
Yang Y; Sun Z; Liu F; Bai Y; Wu F
Cartilage; 2021 Dec; 13(2_suppl):1412S-1420S. PubMed ID: 33834880
[TBL] [Abstract][Full Text] [Related]
20. LncRNA FGD5-AS1 accelerates cell proliferation in pancreatic cancer by regulating miR-520a-3p/KIAA1522 axis.
Lin J; Liao S; Liu Z; Li E; Wu X; Zeng W
Cancer Biol Ther; 2021 Mar; 22(3):257-266. PubMed ID: 33794727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
